PMC:7247521 / 37375-39448
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
626 | 600-608 | Disease | denotes | COVID-19 | MESH:C000657245 |
627 | 850-853 | Disease | denotes | XCH | |
633 | 1278-1312 | Gene | denotes | MXO1 SO1 SX1 WO1 XO1 Main Protease | |
634 | 1420-1424 | Gene | denotes | RdRp | Gene:43740578 |
635 | 1475-1479 | Gene | denotes | RdRp | Gene:43740578 |
636 | 1535-1543 | Gene | denotes | Helicase | Gene:164045 |
637 | 1598-1606 | Gene | denotes | Helicase | Gene:164045 |
639 | 1231-1240 | Species | denotes | 2019-nCov | Tax:2697049 |
641 | 2058-2061 | Disease | denotes | XCH | |
645 | 109-117 | Disease | denotes | COVID-19 | MESH:C000657245 |
646 | 194-197 | Disease | denotes | XCH | |
647 | 228-236 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T569 | 109-117 | SP_7 | denotes | COVID-19 |
T570 | 228-236 | SP_7 | denotes | COVID-19 |
T578 | 600-608 | SP_7 | denotes | COVID-19 |
T579 | 644-648 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T580 | 771-775 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T581 | 1231-1240 | SP_7 | denotes | 2019-nCov |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T147 | 1241-1249 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T148 | 1430-1433 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T149 | 1488-1491 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T150 | 1667-1671 | Body_part | denotes | ExoN | http://purl.org/sig/ont/fma/fma84120 |
T151 | 1911-1918 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T152 | 1971-1978 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T69 | 109-117 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T70 | 228-236 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T71 | 600-608 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T325 | 167-169 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T326 | 531-533 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T327 | 678-679 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T328 | 718-722 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T329 | 1260-1263 | http://purl.obolibrary.org/obo/CLO_0007875 | denotes | MS1 |
T330 | 1260-1263 | http://purl.obolibrary.org/obo/CLO_0052410 | denotes | MS1 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T322 | 644-648 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T323 | 771-775 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T324 | 1241-1249 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T325 | 1544-1547 | Chemical | denotes | ADP | http://purl.obolibrary.org/obo/CHEBI_16761|http://purl.obolibrary.org/obo/CHEBI_456216|http://purl.obolibrary.org/obo/CHEBI_73342 |
T328 | 1911-1918 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T329 | 1971-1978 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T330 | 1979-1982 | Chemical | denotes | ion | http://purl.obolibrary.org/obo/CHEBI_24870 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T103 | 1979-1990 | http://purl.obolibrary.org/obo/GO_0022831 | denotes | ion channel |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T276 | 0-134 | Sentence | denotes | Firstly, the robustness of whole networks against formula attack was assessed to evaluate QFPD attack on the COVID-19 disease network. |
T277 | 135-413 | Sentence | denotes | Interestingly, Table 4 and Fig. 11 showed that MSXG, SGMH, XCH, WLS and Others attack on the COVID-19 network were characterized by greater disturbance score than negative control (BXTM), and increasing dependence on hub nodes, indicating greater fragility under formula attack. |
T278 | 414-525 | Sentence | denotes | In addition, SGMH, MSXG, and Others exerted higher disturbance score than the positive control (YDBF) Table 5 . |
T279 | 526-617 | Sentence | denotes | Fig. 11 Evaluation of the effect of QFPD on the robustness disturbance of COVID-19 network. |
T280 | 618-723 | Sentence | denotes | Blue normal distribution: drug attack on random networks as a null distribution for the permutation test. |
T281 | 724-804 | Sentence | denotes | Red vertical line: the disturbance rate of the drug to the real disease network. |
T282 | 805-882 | Sentence | denotes | Fist row: MXSG, second row: SGMH, third row: XCH, fourth row: WLS, fifth row: |
T283 | 883-890 | Sentence | denotes | Others. |
T284 | 891-1169 | Sentence | denotes | Fist column: average connectivity, second row: average length of shortest path, third row: connection centrality, fourth row: closeness centrality. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) |
T285 | 1170-1250 | Sentence | denotes | Table 5 Docking score between common ingredients of QFPD and 2019-nCov proteins. |
T286 | 1251-1298 | Sentence | denotes | Molecule MS1 MX16 MX17 MX8 MXO1 SO1 SX1 WO1 XO1 |
T287 | 1299-1355 | Sentence | denotes | Main Protease −7.6 −7 −7.8 −7.8 −7.8 −7.2 −7.1 −7.4 −7.4 |
T288 | 1356-1419 | Sentence | denotes | Papain-like protease −8 −8.2 −8.1 −8.1 −8.2 −8.2 −9.2 −8.7 −8.3 |
T289 | 1420-1474 | Sentence | denotes | RdRp with RNA −8.6 −8 −7.9 −7.9 −8 −8.4 −8.2 −8.8 −9.5 |
T290 | 1475-1534 | Sentence | denotes | RdRp without RNA −7.1 −6.8 −6.8 −6.8 −7 −7.1 −6.9 −7.5 −7.1 |
T291 | 1535-1597 | Sentence | denotes | Helicase ADP site −6.2 −6.5 −6.3 −6.1 −6.2 −6.4 −6.8 −6.2 −6.8 |
T292 | 1598-1660 | Sentence | denotes | Helicase NCB site −7.4 −7.1 −7.2 −7.2 −7.5 −7.5 −7.4 −7.6 −7.5 |
T293 | 1661-1715 | Sentence | denotes | Nsp14(ExoN) −7.2 −6.6 −6.6 −6.7 −6.9 −7 −6.9 −7.1 −7.1 |
T294 | 1716-1776 | Sentence | denotes | Nsp14(N7-MTase) −8.6 −8.3 −8.4 −8.3 −8.6 −8.3 −9.4 −8.7 −8.7 |
T295 | 1777-1845 | Sentence | denotes | Nsp15(endoribonuclease) −6.2 −6.8 −6.4 −6.4 −6.3 −6.5 −6.8 −6.4 −6.6 |
T296 | 1846-1908 | Sentence | denotes | Nsp16(2′-O-MTase) −8.1 −7.4 −7.6 −7.8 −7.8 −8.3 −7.7 −8.4 −8.2 |
T297 | 1909-1968 | Sentence | denotes | N protein NCB site −8.1 −7.9 −8 −8 −7.6 −7.8 −7.5 −7.7 −7.9 |
T298 | 1969-2036 | Sentence | denotes | E protein(ion channel) −6.4 −6.9 −7.2 −7.2 −6.9 −6.9 −7.9 −6.8 −6.8 |
T299 | 2037-2065 | Sentence | denotes | M: MXSG, S: SGMH, X: XCH, O: |
T300 | 2066-2073 | Sentence | denotes | Others. |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T8 | 1291-1294 | GlycoEpitope | denotes | WO1 | http://www.glycoepitope.jp/epitopes/AN0690 |